Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MeVis Medical Solutions (M3V) vs. Competitors

3 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:M3VMeVis Medical SolutionsEUR 20.40EUR 37.13M26.84-17.74%―Unlock the DE:M3V analyst price target with TipRanks PremiumDE:M3VUnlock the DE:M3V top-analyst price target with TipRanks Premium
DE:COPCompuGroup MedicalEUR 27.85EUR 1.47B43.4217.91%―Unlock the DE:COP analyst price target with TipRanks PremiumDE:M3V vs DE:COPUnlock the DE:COP top-analyst price target with TipRanks Premium
DE:DRW8Draegerwerk AG & Co. KGaAEUR 83.20EUR 1.81B12.3536.39%―Unlock the DE:DRW8 analyst price target with TipRanks PremiumDE:M3V vs DE:DRW8Unlock the DE:DRW8 top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 14.87EUR 930.47M17.09-7.58%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumDE:M3V vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 27.05EUR 328.82M-7.7530.99%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumDE:M3V vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium
DE:SHLSiemens Healthineers AGEUR 43.30EUR 48.31B21.873.64%Moderate BuyUnlock the DE:SHL analyst price target with TipRanks PremiumDE:M3V vs DE:SHLUnlock the DE:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-40%-20%0%20%40%60%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:M3VMeVis Medical Solutions20.40-4.40-17.74%
DE:COPCompuGroup Medical27.854.5719.63%
DE:DRW8Draegerwerk AG & Co. KGaA83.2023.4839.32%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik14.87-0.75-4.78%
DE:SBSSTRATEC Biomedical27.057.4337.86%
DE:SHLSiemens Healthineers AG43.302.716.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts